Etodolac

Product NDC: 51672-4051
11-digit product format: 516724051
Labeler code: 51672
Product ID: 51672-4051_28681979-a277-8b4c-e063-6394a90a2235
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Etodolac
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Labeler: Taro Pharmaceuticals U.S.A., Inc.
Application: ANDA076174
Marketing category: ANDA
Marketing start: 2003-03-13
Substance: ETODOLAC
Active strength: 400 mg/1
Pharmacologic classes: Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A076174-001	ETODOLAC	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13
A076174-002	ETODOLAC	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13
A076174-003	ETODOLAC	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A076174-001	AB
A076174-002	AB
A076174-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076174-002	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076174-003	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076174-002	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076174-003	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076174-002	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076174-003	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076174-002	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076174-003	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076174-002	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076174-003	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076174-002	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076174-003	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076174-002	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076174-003	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076174-002	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076174-003	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076174-002	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076174-003	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076174-002	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076174-003	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076174-002	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076174-003	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076174-002	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076174-003	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076174-002	ETODOLAC	500MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076174-003	ETODOLAC	600MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076174-001	ETODOLAC	400MG	TABLET, EXTENDED RELEASE / ORAL	AB	2003-03-13	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076174-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076174-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076174-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076174-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076174-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076174-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076174-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076174-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076174-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076174-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076174-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076174-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076174-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076174-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076174-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076174-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076174-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076174-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076174-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076174-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076174-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076174-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076174-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076174-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076174-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076174-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076174-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076174-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076174-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076174-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076174-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076174-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076174-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076174-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076174-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076174-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076174-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076174-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076174-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076174-001	AB	1	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: Etodolac
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ETODOLAC	400 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2M36281008	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
310245	Internal RxNorm lookup
310247	Internal RxNorm lookup
359500	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2c5b44b4-78d5-43b2-827d-d2763b6672b3	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bb9faa76-10d1-4b5f-ab9b-d6a26495edb7	Product name	1	20250311
0c3d95a8-02c3-425e-810b-2a14408d9a06	Product name	4	20250218
351abe41-466c-4dd8-840a-0fdb68318bd5	Product name	1	20230316
24aa5265-325f-0e21-8836-2c9a907c0454	Product name	2	20210601

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
51672-4051-1	Etodolac	100 in 1 BOTTLE	TABLET, EXTENDED RELEASE	100	7
51672-4051-2	Etodolac	500 in 1 BOTTLE	TABLET, EXTENDED RELEASE	500	7
51672-4051-3	Etodolac	1000 in 1 BOTTLE	TABLET, EXTENDED RELEASE	1000	7
51672-4051-4	Etodolac	60 in 1 BOTTLE	TABLET, EXTENDED RELEASE	60	7
51672-4051-6	Etodolac	30 in 1 BOTTLE	TABLET, EXTENDED RELEASE	30	7
51672-4051-9	Etodolac	10 in 1 CARTON	TABLET, EXTENDED RELEASE	10	7
51672-4051-9	Etodolac	6 in 1 BLISTER PACK	TABLET, EXTENDED RELEASE	6	7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
51672-4051-1	EA - Each	51672-4051	af3a7808-071d-4f1c-8d9e-bc907d62cf5c	1	2012-07-24
51672-4051-4	EA - Each	51672-4051	c205efe2-a07b-4ddf-b5ef-37bc62121237	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Etodolac	ACTIVE INGREDIENT	2M36281008	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
Etodolac	ACTIVE MOIETY	2M36281008	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
Aluminum Oxide	INACTIVE INGREDIENT	LMI26O6933	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
Anhydrous Lactose	INACTIVE INGREDIENT	3SY5LH9PMK	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
Cellulose, Microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
FD&C Red No. 40	INACTIVE INGREDIENT	WZB9127XOA	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
FD&C Yellow No. 6	INACTIVE INGREDIENT	H77VEI93A8	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
Ferric Oxide Yellow	INACTIVE INGREDIENT	EX438O2MRT	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
Hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
Indigotindisulfonate Sodium	INACTIVE INGREDIENT	D3741U8K7L	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
Magnesium Stearate	INACTIVE INGREDIENT	70097M6I30	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
Polydextrose	INACTIVE INGREDIENT	VH2XOU12IE	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
Polyethylene Glycol 8000	INACTIVE INGREDIENT	Q662QK8M3B	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
Povidones	INACTIVE INGREDIENT	FZ989GH94E	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
Titanium Dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2
Triacetin	INACTIVE INGREDIENT	XHX3C3X673	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51672-4051	ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.]	7	Current NDC, Legacy NDC, 7 package rows	20241206_2c5b44b4-78d5-43b2-827d-d2763b6672b3.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Etodolac	ETODOLAC	TaSun Pharmaceutical Industries, Inc.	2c5b44b4-78d5-43b2-827d-d2763b6672b3	2026-07-14	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076174 application number: ANDA076174 ndc (product): 51672-4051
Etodolac	ETODOLAC	NORTHSTAR RX LLC	107ea9d7-80a9-41a4-b61e-168370127319	2025-06-24	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076174 application number: ANDA076174
Etodolac ER	ETODOLAC	Advanced Rx Pharmacy of Tennessee, LLC	d294d541-3049-6bfe-e053-2995a90a23ea	2024-12-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076174 application number: ANDA076174
Etodolac ER	ETODOLAC	Advanced Rx Pharmacy of Tennessee, LLC	baebdfb2-17f6-9081-e053-2a95a90ab331	2024-12-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076174 application number: ANDA076174
Etodolac	ETODOLAC	Golden State Medical Supply, Inc.	c59c5108-a09b-2a03-e053-2995a90abba1	2024-12-26	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076174 application number: ANDA076174
Etodolac	ETODOLAC	Proficient Rx LP	449b273a-936a-4c49-b0c8-d0daa47733ae	2019-11-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 076174 application number: ANDA076174

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
2M36281008	ETODOLAC	41340-25-4	ETODOLAC

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310245	etodolac 400 MG 24HR Extended Release Oral Tablet	PSN	2c5b44b4-78d5-43b2-827d-d2763b6672b3	7
359500	etodolac 500 MG 24HR Extended Release Oral Tablet	PSN	2c5b44b4-78d5-43b2-827d-d2763b6672b3	7
310247	etodolac 600 MG 24HR Extended Release Oral Tablet	PSN	2c5b44b4-78d5-43b2-827d-d2763b6672b3	7
310245	24 HR etodolac 400 MG Extended Release Oral Tablet	SCD	2c5b44b4-78d5-43b2-827d-d2763b6672b3	7
359500	24 HR etodolac 500 MG Extended Release Oral Tablet	SCD	2c5b44b4-78d5-43b2-827d-d2763b6672b3	7
310247	24 HR etodolac 600 MG Extended Release Oral Tablet	SCD	2c5b44b4-78d5-43b2-827d-d2763b6672b3	7
310245	etodolac 400 MG 24 HR Extended Release Oral Tablet	SY	2c5b44b4-78d5-43b2-827d-d2763b6672b3	7
359500	etodolac 500 MG 24 HR Extended Release Oral Tablet	SY	2c5b44b4-78d5-43b2-827d-d2763b6672b3	7
310247	etodolac 600 MG 24 HR Extended Release Oral Tablet	SY	2c5b44b4-78d5-43b2-827d-d2763b6672b3	7
310245	etodolac 400 MG 24HR Extended Release Oral Tablet	PSN	c59c5108-a09b-2a03-e053-2995a90abba1	4
359500	etodolac 500 MG 24HR Extended Release Oral Tablet	PSN	c59c5108-a09b-2a03-e053-2995a90abba1	4
310247	etodolac 600 MG 24HR Extended Release Oral Tablet	PSN	c59c5108-a09b-2a03-e053-2995a90abba1	4
310245	24 HR etodolac 400 MG Extended Release Oral Tablet	SCD	c59c5108-a09b-2a03-e053-2995a90abba1	4
359500	24 HR etodolac 500 MG Extended Release Oral Tablet	SCD	c59c5108-a09b-2a03-e053-2995a90abba1	4
310247	24 HR etodolac 600 MG Extended Release Oral Tablet	SCD	c59c5108-a09b-2a03-e053-2995a90abba1	4
310245	etodolac 400 MG 24 HR Extended Release Oral Tablet	SY	c59c5108-a09b-2a03-e053-2995a90abba1	4
359500	etodolac 500 MG 24 HR Extended Release Oral Tablet	SY	c59c5108-a09b-2a03-e053-2995a90abba1	4
310247	etodolac 600 MG 24 HR Extended Release Oral Tablet	SY	c59c5108-a09b-2a03-e053-2995a90abba1	4
310245	etodolac 400 MG 24HR Extended Release Oral Tablet	PSN	449b273a-936a-4c49-b0c8-d0daa47733ae	3
310245	24 HR etodolac 400 MG Extended Release Oral Tablet	SCD	449b273a-936a-4c49-b0c8-d0daa47733ae	3
310245	etodolac 400 MG 24 HR Extended Release Oral Tablet	SY	449b273a-936a-4c49-b0c8-d0daa47733ae	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
51672-4051-1	51672405101	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4051-1)		2003-03-13	0000-00-00	No	No	Current
51672-4051-2	51672405102	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4051-2)		2003-03-13	0000-00-00	No	No	Current
51672-4051-3	51672405103	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4051-3)		2003-03-13	0000-00-00	No	No	Current
51672-4051-4	51672405104	60 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4051-4)		2003-03-13	0000-00-00	No	No	Current
51672-4051-6	51672405106	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4051-6)		2003-03-13	0000-00-00	No	No	Current
51672-4051-9	51672405109	10 BLISTER PACK in 1 CARTON (51672-4051-9) / 6 TABLET, EXTENDED RELEASE in 1 BLISTER PACK	10 blister pack	2003-03-13	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Etodolac Extended-Release Tablets, 400 mg, 500 mg and 600 mg	TaSun Pharmaceutical Industries, Inc. \| Taro Pharmaceutical Industries Ltd.	2026-07-14	HUMAN PRESCRIPTION DRUG LABEL	8
Etodolac Extended-Release Tablets, 400 mg, 500 mg and 600 mg	Golden State Medical Supply, Inc.	2024-12-26	HUMAN PRESCRIPTION DRUG LABEL	4
Etodolac Extended-Release Tablets, 400 mg, 500 mg and 600 mg	Proficient Rx LP	2019-11-01	HUMAN PRESCRIPTION DRUG LABEL	3